Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCLASS study of intravenous clarithromycin in sepsis with respiratory and multiple organ dysfunction
2017-001056-55Phase 4Completed
- Sponsor
- Hellenic Institute for the Study of Sepsis
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin in sepsis, sponsored by Hellenic Institute for the Study of Sepsis. Started Jun 2017; status: completed.
02
Drugs
clarithromycin
03
Conditions
sepsis
Beyond the preview
Go deeper on 2017-001056-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001056-55.